Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results
March 30, 2016 08:00 ET
|
Editas Medicine, Inc.
Well-positioned to advance multiple programs and continue expansion of genome editing platform Cash balance of approximately $230 million funds diversified pipeline Executive team and board of...